General Information of Drug (ID: DMBOV5P)

Drug Name
Sodium oxybate Drug Info
Synonyms
Sodium oxybate; Oxybate sodium; Sodium Oxybutyrate; Anetamin; Sodium 4-hydroxybutyrate; 4-Hydroxybutyric acid sodium salt; Somsanit; 502-85-2; Catabate; Sodium gamma-hydroxybutyrate; Sodium oxybat; Gamma OH; 4-Hydroxybutyrate sodium; Natrium 4-hydroxybutyrat; Sodium Oxybate [USAN]; Sodium-4-hydroxybutyrate; gamma-Hydroxybutyrate sodium; LUMRYZ; gamma-Hydroxy sodium butyrate; Butanoic acid, 4-hydroxy-, monosodium salt; 4-Hydroxybuttersaeure natriumsalz; gamma-Hydroxybutyrate sodium salt; sodium 4-hydroxybutanoate; WY-3478; Oxybate (sodium); EINECS 207-953-3; JZP-6; NSC 84223; gamma-Hydroxybutyric acid, sodium salt; Butanoic acid, 4-hydroxy-, sodium salt; DTXSID3048940; EB 27; Hydroxybutyric acid monosodium salt; 4-Hydroxybutyric acid monosodium salt; NSC-84223; Sodium gammahydroxybutyrate; UNII-7G33012534; WY 3478; Butyric acid, 4-hydroxy-, monosodium salt; DTXCID6028866; GHB.sodium salt; BUTYRIC ACID, 4-HYDROXY-, SODIUM SALT; .gamma.-hydroxybutyrate sodium salt; XYWAV COMPONENT SODIUM OXYBATE; 7G33012534; SODIUM OXYBATE COMPONENT OF XYWAV; Sodium oxybate (USAN); SODIUM OXYBATE (MART.); SODIUM OXYBATE [MART.]; Oxybate, Sodium; Oxybutyrate, Sodium; NSC84223; GHB Sodium Salt (Sodium Gammahydroxybutyrate); 4 Hydroxybutyrate Sodium; NCGC00247714-01; Sodium gamma Hydroxybutyrate; Acetamide,2,2-dichloro-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]-,rel-; Xyrem (TN); SCHEMBL61823; SODIUM OXYBATE [HSDB]; SODIUM OXYBATE [VANDF]; DEA No. 2012; CHEMBL1200682; OXYBATE SODIUM [WHO-DD]; SODIUM OXYBATE [EMA EPAR]; XYGBKMMCQDZQOZ-UHFFFAOYSA-M; HMS2091E15; ; A-Hydroxybutyric acid sodium salt; HY-B1187; Tox21_112871; gamma-Hydroxybutyric acid sodium salt; SODIUM OXYBATE [ORANGE BOOK]; Gamma Hydroxybutyric Acid preparations; GHB.sodium salt, 1mg/ml in Methanol; AKOS006221428; CCG-212465; CS-4796; DB09072; CAS-502-85-2; FT-0626615; D05866; H-4040; SODIUM SALT OF GAMMA-HYDROXYBUTYRIC ACID; .GAMMA.-HYDROXYBUTYRATE SODIUM SALT [MI]; Butanoic acid, 4-hydroxy-, sodium salt (1:1); Q7553347; ?-Hydroxybutyric Acid Sodium Salt (1.0 mg/mL in Methanol)
Indication
Disease Entry ICD 11 Status REF
Narcolepsy 7A20 Approved [1]
Narcolepsy type 1 7A20.0 Approved [2]
Cross-matching ID
PubChem CID
23663870
TTD Drug ID
DMBOV5P

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DME
DOT
Drug Status:
Approved Drug(s)
Drug(s) Affected By Somatotropin (GH1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Polyethylene glycol DM4I1JP Constipation DD91.1 Approved [6]
Clonidine DM6RZ9Q Attention deficit hyperactivity disorder 6A05.Z Approved [7]
Adenosine triphosphate DM79F6G Malnutrition 5B50-5B71 Approved [8]
Cyproheptadine DM92AH3 Allergic rhinitis CA08.0 Approved [9]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [10]
Ethanol DMDRQZU Chronic pain MG30 Approved [6]
Connexyn DMF29Q5 Attention deficit hyperactivity disorder 6A05.Z Approved [11]
Gamma Hydroxybutyric Acid DMGBKVD Narcolepsy 7A20 Approved [12]
Hydrocortisone DMGEMB7 Acne vulgaris ED80 Approved [13]
Octreotide DMHIDCJ Acromegaly 5A60.0 Approved [14]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug-Metabolizing Enzyme (DME)
DME Name DME ID UniProt ID MOA REF
Hydroxyacid-oxoacid transhydrogenase (ADHFE1) DE8RJ3F HOT_HUMAN Substrate [3]
Succinate-semialdehyde dehydrogenase (ALDH5A1) DE5KEWZ SSDH_HUMAN Substrate [4]

Drug Off-Target (DOT)
DOT Name DOT ID UniProt ID Interaction REF
Somatotropin (GH1) OT92RTRD SOMA_HUMAN Gene/Protein Processing [5]

References

1 FDA Approved Drug Products from FDA Official Website.
2 Sodium oxybate FDA Label
3 Kinetic characterization of human hydroxyacid-oxoacid transhydrogenase: relevance to D-2-hydroxyglutaric and gamma-hydroxybutyric acidurias. J Inherit Metab Dis. 2005;28(6):921-30.
4 Redox-switch modulation of human SSADH by dynamic catalytic loop. EMBO J. 2009 Apr 8;28(7):959-68.
5 Failure of gammahydroxy butyric acid to stimulate growth hormone secretion in cocaine addicts. Neuropeptides. 1997 Oct;31(5):459-62. doi: 10.1016/s0143-4179(97)90040-8.
6 Metal-catalyzed oxidation of human growth hormone: modulation by solvent-induced changes of protein conformation. J Pharm Sci. 2001 Jan;90(1):58-69. doi: 10.1002/1520-6017(200101)90:1<58::aid-jps7>3.0.co;2-w.
7 Assessment of MK-912, an alpha 2-adrenoceptor antagonist, with use of intravenous clonidine. Clin Pharmacol Ther. 1989 Jul;46(1):103-9. doi: 10.1038/clpt.1989.113.
8 Phosphatidylinositol 4-OH kinase is a downstream target of neuronal calcium sensor-1 in enhancing exocytosis in neuroendocrine cells. J Biol Chem. 2003 Feb 21;278(8):6075-84. doi: 10.1074/jbc.M204702200. Epub 2002 Dec 5.
9 [Toxicity of cyproheptadine. Side effects and accidental overdosage (author's transl)]. Monatsschr Kinderheilkd (1902). 1978 Mar;126(3):123-6.
10 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
11 Effect of centrally acting alpha-adrenergic agonists on sympathetic nervous system function in humans. Hypertension. 1984 Sep-Oct;6(5 Pt 2):II57-62. doi: 10.1161/01.hyp.6.5_pt_2.ii57.
12 Thyrotropin-releasing hormone-induced GH release after cocaine withdrawal in cocaine addicts. Neuropeptides. 1999 Dec;33(6):522-5. doi: 10.1054/npep.1999.0773.
13 Effects of cortisol and cocaine on plasma prolactin and growth hormone levels in cocaine-dependent volunteers. Addict Behav. 2005 May;30(4):859-64. doi: 10.1016/j.addbeh.2004.08.019.
14 Effect of a somatostatin analogue, octreotide, on renal haemodynamics and albuminuria in acromegalic patients. Eur J Clin Invest. 1992 Jul;22(7):494-502. doi: 10.1111/j.1365-2362.1992.tb01496.x.